Prion Disease Therapeutics
$368,950ZIAFY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications & trials
Paper 38632492Paper 33610557Paper 31361599Paper 30412823Paper 29133563Paper 27012425Paper 25027691Paper 24900756Paper 24648544Paper 24400098Paper 22493139Paper 19913031Paper 19200018
Abstract
The transmissible spongiform encephalopathies (TSEs or prion diseases)are fatal untreatable neurodegenerative diseases such as scrapie, Creutzfeldt-Jakob disease (CJD), bovine spongiform encephalopathy and chronic wasting disease (CWD). TSE pathogenesis involves the accumulation of an abnormal misfolded protein, called PrPres, in infected hosts. This fiscal year, we have extended studies of the influence of chaperone proteins and peptides on PrPres formation. One chaperone protein was found to act as an inhibitor.
View original record on NIH RePORTER →